Artificial bile ducts successfully grown in lab and transplanted into mice could help treat liver disease in children

New method opens the way to develop future treatments and reduce the need for liver transplants

Artificial bile ducts successfully grown in lab and transplanted into mice could help treat liver disease in children

Vallier_Homepage.jpg
Researchers have grown human cells into 3-D tubes that can then be used to repair damaged bile ducts in mice. The method they have developed opens the way to develop future liver treatments that don't involve transplantation.

Cambridge scientists have developed a new method for growing and transplanting artificial bile ducts that could in future be used to help treat liver disease in children, reducing the need for liver transplantation.

In research published in the journal Nature Medicine, the researchers grew 3D cellular structure which, once transplanted into mice, developed into normal, functioning bile ducts.

vallierbody2.png
3D organoids growing with structural and functional similarities to normal, healthy bile ducts.  Scale bars: 100 μm

Bile ducts are long, tube-like structures that carry bile secreted by the liver and essential for helping us digest food. If the ducts do not work correctly, for example in the childhood disease biliary atresia, this can lead to damaging build of bile in the liver and the need for a liver transplant.

The study suggests that it will be feasible to generate and transplant artificial human bile ducts using a combination of cell transplantation and tissue engineering technology. This approach provides hope for the future treatment of diseases of the bile duct; at present, the only option is a liver transplant.

The University of Cambridge research team, led by Professor Ludovic Vallier and Dr Fotios Sampaziotis from the Wellcome – MRC Cambridge Stem Cell Institute and Dr Kourosh Saeb-Parsy from the Department of Surgery, extracted healthy cells (cholangiocytes) from bile ducts and grew these into functioning 3D duct structures known as biliary organoids.  When transplanted into mice, the biliary organoids assembled into intricate tubular structures, resembling bile ducts.

The researchers, in collaboration with Mr Alex Justin and Dr Athina Markaki from the Department of Engineering, then investigated whether the biliary organoids could be grown on a “biodegradable collagen scaffold”, which could be shaped into a tube and used to repair damaged bile ducts in the body.  After four weeks, the cells had fully covered the miniature scaffolding resulting in artificial tubes which exhibited key features of a normal, functioning bile duct.  These artificial ducts were then used to replace damaged bile ducts in mice.  The artificial duct transplants were successful, with the animals surviving without further complications. 

“Our work has the potential to transform the treatment of bile duct disorders. At the moment, our only option is liver transplantation, so we are limited by the availability of healthy organs for transplantation. In future, we believe it will be possible to generate large quantities of bioengineered tissue that could replace diseased bile ducts and provide a powerful new therapeutic option without this reliance on organ transplants.”

Professor Ludovic Vallier, senior author of the paper from the Wellcome – MRC Cambridge Stem Cell Institute and a senior Group Leader at the Wellcome Trust Sanger Institute

“This demonstrates the power of tissue engineering and regenerative medicine. These artificial bile ducts will not only be useful for transplanting, but could also be used to model other diseases of the bile duct and potentially develop new drug treatments.”

Dr Fotios Sampaziotis, first author on the paper, from the Wellcome – MRC Cambridge Stem Cell Institute

Professor Vallier is part of the Department of Surgery at the University of Cambridge and his team are jointly based at the Wellcome Trust – MRC Cambridge Stem Cell Institute and the Wellcome Trust Sanger Institute.

The support of the Medical Research Council, Sparks children’s medical research charity and the European Research Council has been invaluable in facilitating this research, and is gratefully acknowledged by Ludovic and the team.

Notes to Editors
Publication:

Sampaziotis F et al. (2017) Reconstruction of the murine extrahepatic biliary tree using primary extrahepatic cholangiocyte organoids. Nature MedicineDOI: 10.1038/nm.4360

Funding:

This work was funded by the Medical Research Council, European Research Council and the Sparks children’s medical charity.

Selected Websites
Contact the Press Office

Dr Samantha Wynne

Media Officer

Wellcome Trust Sanger Institute,
Hinxton,
Cambridgeshire,
CB10 1SA,
UK

Tel +44 (0)1223 492 368

Mobile +44 (0) 7900 607793

Fax +44 (0)1223 494 919

Recent News

Present-day Lebanese descend from Biblical Canaanites, genetic study suggests

Scientists sequenced the genomes of 4,000-year-old Canaanite individuals and compared these to other ancient and present-day populations

New global health initiative for genomic surveillance of antimicrobial resistance funded by NIHR

The Centre for Genomic Pathogen Surveillance to house the Global Health Research Unit to monitor antibiotic resistant bacteria around the globe

MRSA emerged years before methicillin was even discovered

Study shows that Staphylococcus aureus acquired the mecA methicillin resistance gene in the mid-1940s